DE60333776D1 - Pharmazeutische und kosmetische zubereitungen - Google Patents

Pharmazeutische und kosmetische zubereitungen

Info

Publication number
DE60333776D1
DE60333776D1 DE60333776T DE60333776T DE60333776D1 DE 60333776 D1 DE60333776 D1 DE 60333776D1 DE 60333776 T DE60333776 T DE 60333776T DE 60333776 T DE60333776 T DE 60333776T DE 60333776 D1 DE60333776 D1 DE 60333776D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
cosmetic preparations
silicon dioxide
cosmetic formulations
highly disperse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60333776T
Other languages
English (en)
Inventor
Steffen Hasenzahl
Margarete Drechsler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Priority to DE60333776T priority Critical patent/DE60333776D1/de
Application granted granted Critical
Publication of DE60333776D1 publication Critical patent/DE60333776D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60333776T 2002-10-31 2003-10-07 Pharmazeutische und kosmetische zubereitungen Expired - Lifetime DE60333776D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60333776T DE60333776D1 (de) 2002-10-31 2003-10-07 Pharmazeutische und kosmetische zubereitungen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10250711A DE10250711A1 (de) 2002-10-31 2002-10-31 Pharmazeutische und kosmetische Zubereitungen
DE60333776T DE60333776D1 (de) 2002-10-31 2003-10-07 Pharmazeutische und kosmetische zubereitungen
PCT/EP2003/011054 WO2004039349A1 (en) 2002-10-31 2003-10-07 Pharmaceutical and cosmetic formulations

Publications (1)

Publication Number Publication Date
DE60333776D1 true DE60333776D1 (de) 2010-09-23

Family

ID=32115006

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10250711A Ceased DE10250711A1 (de) 2002-10-31 2002-10-31 Pharmazeutische und kosmetische Zubereitungen
DE60333776T Expired - Lifetime DE60333776D1 (de) 2002-10-31 2003-10-07 Pharmazeutische und kosmetische zubereitungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10250711A Ceased DE10250711A1 (de) 2002-10-31 2002-10-31 Pharmazeutische und kosmetische Zubereitungen

Country Status (10)

Country Link
US (1) US20060292192A1 (de)
EP (1) EP1558212B1 (de)
JP (1) JP2006506388A (de)
KR (1) KR100755193B1 (de)
CN (1) CN100488565C (de)
AT (1) ATE476959T1 (de)
AU (1) AU2003276059A1 (de)
DE (2) DE10250711A1 (de)
ES (1) ES2350742T3 (de)
WO (1) WO2004039349A1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
JP5767429B2 (ja) 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
DE10320197A1 (de) * 2002-12-20 2004-07-08 Degussa Ag Umhüllte Persauerstoffverbindungen mit kontrollierter Freisetzung, Verfahren zu ihrer Herstellung und ihrer Verwendung
JP2007509036A (ja) * 2003-05-23 2007-04-12 デグサ　アクチエンゲゼルシャフト 過酸化水素及び疎水化二酸化ケイ素を含有する粉体状混合物
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
WO2005058256A1 (de) * 2003-12-01 2005-06-30 Degussa Ag Verstreichbare kosmetische zubereitung mit hohem wassergehalt
DE102004031785A1 (de) * 2004-07-01 2006-01-26 Degussa Ag Polyol enthaltende Siliciumdioxid-Dispersion
DE102004037044A1 (de) 2004-07-29 2006-03-23 Degussa Ag Mittel zur Ausstattung von auf Cellulose und/oder Stärke basierenden Substraten mit Wasser abweisenden und gleichzeitig pilz-, bakterien-, insekten- sowie algenwidrigen Eigenschaften
DE102004037045A1 (de) 2004-07-29 2006-04-27 Degussa Ag Wässrige Silan-Nanokomposite
US8969379B2 (en) * 2004-09-17 2015-03-03 Eisai R&D Management Co., Ltd. Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
DE102004049427A1 (de) 2004-10-08 2006-04-13 Degussa Ag Polyetherfunktionelle Siloxane, polyethersiloxanhaltige Zusammensetzungen, Verfahren zu deren Herstellung und deren Verwendung
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
DE102004056862A1 (de) * 2004-11-25 2006-06-14 Degussa Ag Pulverförmige, kosmetische Zubereitung mit hohem Wassergehalt
DE102005055226A1 (de) * 2004-12-24 2006-07-13 Degussa Ag Lagerung pulverförmiger Stoffe mit hohem Wassergehalt
DE102005004872A1 (de) 2005-02-03 2006-08-10 Degussa Ag Wässrige Emulsionen von funktionellen Alkoxysilanen und deren kondensierten Oligomeren, deren Herstellung und Verwendung zur Oberflächenbehandlung
DE102005032427A1 (de) * 2005-07-12 2007-01-18 Degussa Ag Aluminiumoxid-Dispersion
WO2007015578A1 (ja) * 2005-08-02 2007-02-08 Eisai R & D Management Co., Ltd. 血管新生阻害物質の効果を検定する方法
DE102006006656A1 (de) 2005-08-26 2007-03-01 Degussa Ag Silan enthaltendes Bindemittel für Verbundwerkstoffe
DE102006006655A1 (de) * 2005-08-26 2007-03-01 Degussa Ag Cellulose- bzw. lignocellulosehaltige Verbundwerkstoffe auf der Basis eines auf Silan basierenden Komposits als Bindemittel
EP1951266A2 (de) 2005-09-02 2008-08-06 Genzyme Corporation Verfahren zur entfernung von phosphat und dafür verwendetes polymer
BRPI0616078B8 (pt) 2005-09-15 2021-05-25 Genzyme Corp pó de uma formulação farmacêutica de polímero de amina, uso de tal pó e formulação em sachê para polímeros de amina
DE102005053071A1 (de) 2005-11-04 2007-05-16 Degussa Verfahren zur Herstellung von ultrafeinen Pulvern auf Basis Polymaiden, ultrafeinen Polyamidpulver sowie deren Verwendung
WO2007052849A1 (ja) 2005-11-07 2007-05-10 Eisai R & D Management Co., Ltd. 血管新生阻害物質とc-kitキナーゼ阻害物質との併用
EP1813573A1 (de) * 2006-01-25 2007-08-01 Degussa GmbH Verfahren zur Herstellung von Gummimischungen
DE102006017701A1 (de) * 2006-04-15 2007-10-25 Degussa Gmbh Silicium-Titan-Mischoxidpulver, Dispersion hiervon und daraus hergestellter titanhaltiger Zeolith
ES2688931T3 (es) * 2006-05-05 2018-11-07 Blaa Lonid Hf. Uso farmacéutico y cosmético de la sílice
EP2023899A1 (de) * 2006-05-10 2009-02-18 Evonik Degussa GmbH Verwendung von rollen-kompaktiertem pyrogen hergestelltem siliziumdioxid in pharmazeutischen zusammensetzungen
WO2007128349A1 (en) * 2006-05-10 2007-11-15 Evonik Degussa Gmbh Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
CA2652442C (en) 2006-05-18 2014-12-09 Eisai R & D Management Co., Ltd. Antitumor agent for thyroid cancer
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
DE102006039269A1 (de) * 2006-08-22 2008-02-28 Evonik Degussa Gmbh Dispersion von Aluminiumoxid, Beschichtungszusammensetzung und tintenaufnehmendes Medium
US8155674B2 (en) * 2006-08-22 2012-04-10 Research In Motion Limited Apparatus, and associated method, for dynamically configuring a page message used to page an access terminal in a radio communication system
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
CA2676796C (en) 2007-01-29 2016-02-23 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated gastric cancer
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
ES2725499T3 (es) 2007-04-20 2019-09-24 Evonik Degussa Gmbh Mezcla que contiene un compuesto de organosilicio y su uso
DE102007038314A1 (de) 2007-08-14 2009-04-16 Evonik Degussa Gmbh Verfahren zur kontrollierten Hydrolyse und Kondensation von Epoxy-funktionellen Organosilanen sowie deren Condensation mit weiteren organofunktionellen Alkoxysilanen
DE102007040246A1 (de) * 2007-08-25 2009-02-26 Evonik Degussa Gmbh Strahlenhärtbare Formulierungen
DE102008007261A1 (de) 2007-08-28 2009-03-05 Evonik Degussa Gmbh Wässrige Silansysteme basierend auf Bis(trialkoxysilyalkyl)aminen
DE102007049743A1 (de) * 2007-10-16 2009-04-23 Evonik Degussa Gmbh Silicium-Titan-Mischoxidpulver, Dispersion hiervon und daraus hergestellter titanhaltiger Zeolith
WO2009060945A1 (ja) * 2007-11-09 2009-05-14 Eisai R & D Management Co., Ltd. 血管新生阻害物質と抗腫瘍性白金錯体との併用
KR101569227B1 (ko) 2008-03-11 2015-11-13 아스카 세이야쿠 가부시키가이샤 고체 분산체와 그 의약 조성물, 그리고 그들의 제조 방법
US10039718B2 (en) * 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent
DE102009002499A1 (de) 2009-04-20 2010-10-21 Evonik Degussa Gmbh Dispersion enthaltend mit quartären, aminofunktionellen siliciumorganischen Verbindungen oberflächenmodifizierte Siliciumdioxidpartikel
DE102009002477A1 (de) 2009-04-20 2010-10-21 Evonik Degussa Gmbh Quartäre-aminofunktionelle, siliciumorganische Verbindungen enthaltende Zusammensetzung sowie deren Herstellung und Verwendung
WO2011073408A2 (en) * 2009-12-18 2011-06-23 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide
EP2387993B1 (de) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Zolmitriptan-Tabletten und Herstellungsverfahren dafür
EP2586443B1 (de) 2010-06-25 2016-03-16 Eisai R&D Management Co., Ltd. Antitumorwirkstoff mit verbindungen mit kinasehemmungswirkung in kombination
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2705950T3 (es) 2011-06-03 2019-03-27 Eisai R&D Man Co Ltd Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
US9549894B2 (en) * 2012-06-21 2017-01-24 L'oreal Water-releasing cosmetic composition including a hydrophobic silica
CN104755463A (zh) 2012-12-21 2015-07-01 卫材R&D管理有限公司 非晶态形式的喹啉衍生物及其生产方法
MX368099B (es) 2013-05-14 2019-09-19 Eisai R&D Man Co Ltd Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
JO3783B1 (ar) 2014-08-28 2021-01-31 Eisai R&D Man Co Ltd مشتق كوينولين عالي النقاء وطريقة لإنتاجه
DK3263106T3 (da) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
CN107801379B (zh) 2015-06-16 2021-05-25 卫材R&D管理有限公司 抗癌剂
US20210106531A1 (en) * 2018-01-29 2021-04-15 Pathelen Health Care Ag Hydrophilic/hydrophobic pharmaceutical composition and method of its production and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034077A (en) * 1973-01-02 1977-07-05 E. R. Squibb & Sons, Inc. Ointments and powders containing sebacic acid
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US6193795B1 (en) * 1993-08-02 2001-02-27 Degussa Corporation Low structure pyrogenic hydrophilic and hydrophobic metallic oxides, production and use
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) * 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
EP0725037B2 (de) * 1995-02-04 2012-04-25 Evonik Degussa GmbH Granulate auf Basis von pyrogen hergestelltem Siliciumdioxid, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2781162B1 (fr) * 1998-07-17 2000-11-17 Andre Mazaury Procede de traitement cosmetique de la peau, du cuir chevelu et de leurs derives utilisant des ondes electro-magnetiques et des huiles essentielles
JP4352592B2 (ja) * 2000-07-11 2009-10-28 コニカミノルタホールディングス株式会社 セルロースエステルドープ組成物、セルロースエステルフィルムの製造方法、セルロースエステルフィルム及びそれを用いた偏光板
ATE225162T1 (de) * 2000-07-13 2002-10-15 Oreal Kosmetisches reinigungsmittel
KR20020039976A (ko) * 2000-11-23 2002-05-30 조충환 펑크 대비용 공기입 타이어
DE10126163A1 (de) * 2001-05-30 2002-12-05 Degussa Pharmazeutische Zubereitungen
FR2827515B1 (fr) * 2001-07-20 2005-06-03 Oreal Composition moussante a base de silice et de polymere cationique
US6951642B2 (en) * 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods

Also Published As

Publication number Publication date
CN1708287A (zh) 2005-12-14
AU2003276059A8 (en) 2004-05-25
DE10250711A1 (de) 2004-05-19
EP1558212A1 (de) 2005-08-03
ES2350742T3 (es) 2011-01-26
CN100488565C (zh) 2009-05-20
WO2004039349A1 (en) 2004-05-13
KR20050071632A (ko) 2005-07-07
EP1558212B1 (de) 2010-08-11
ATE476959T1 (de) 2010-08-15
US20060292192A1 (en) 2006-12-28
JP2006506388A (ja) 2006-02-23
KR100755193B1 (ko) 2007-09-05
AU2003276059A1 (en) 2004-05-25
WO2004039349A8 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
DE60333776D1 (de) Pharmazeutische und kosmetische zubereitungen
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
DE60127551D1 (de) Silikonverbindung und kosmetische zubereitung
BR0211769A (pt) Combinações antineoplásicas
DK1264602T3 (da) Farmaceutiske præparater
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
ATE282428T1 (de) Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
CY1108874T1 (el) ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ
DE50105387D1 (de) Elektrolythaltige kosmetische, pharmazeutische und dermatologische mittel
DE69925133D1 (de) Pyrrolobenzodiazepine
DE50211581D1 (de) Tensidefreie kosmetische, dermatologische und pharmazeutische Mittel
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
ATA13842001A (de) Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE50213084D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
EE200200283A (et) Zolmitriptaani sisaldavad ravimpreparaadid
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATE314084T1 (de) Kahalalid f formulierung
DE50212687D1 (de) Kosmetische und/oder pharmazeutische emulsionen
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
BR0308762A (pt) Formulação farmacêutica compreendendo melatonina
DE602004015994D1 (de) Selbstemulgierende und selbstmicroemulgierende formulierungen zur oralen verabreichung von taxoiden
DE59812317D1 (de) "Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron"
SE0001916D0 (sv) Novel formulation